Joerg Buchmann

Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland

Sabine Hombach‐Klonisch, Joerg Buchmann, Sukhéna Sarun et al. · Cancer · 2000 · 46 citations · Full text

Life Sciences, Molecular Biology, Oncology +13

Tenascin—A Marker for the Malignant Potential of Preinvasive Breast Cancers

Christian Goepel, Joerg Buchmann, Ruediger Schultka et al. · Gynecologic Oncology · 2000 · 22 citations

Medicine, Cancer Biology, Oncology +13

Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization – design and objectives of the Diagnosis Optimisation Study (DIOS)

Alexander Kluttig, Pietro Trocchi, A. Heinig et al. · BMC Cancer · 2007 · 12 citations · Full text

Medicine, Pathology, Radiology +17

Histological category and expression of hormone receptors in ductal carcinoma in situ of the breast.

Antje Lebrecht, Joerg Buchmann, Lukas Hefler et al. · PubMed · 2002 · 11 citations

Medicine, Oncology, Pathology +17

CHAMP: A Phase II Study of Panitumumab With Pemetrexed and Cisplatin Versus Pemetrexed and Cisplatin in the Treatment of Patients With Advanced-Stage Primary Nonsquamous Non–Small-Cell Lung Cancer With Particular Regard to the KRAS Status

Wolfgang Schuette, Dirk Behringer, Jan Stoehlmacher et al. · Clinical Lung Cancer · 2015 · 10 citations

Medicine, Oncology, Pharmacology +16